|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Discount accretion and other debt-related costs | |||||
| Provision for uncollectible amounts | |||||
| Change in fair value of warrant liability | |||||
| Changes in assets and liabilities: | |||||
| Receivables | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued compensation and related costs | |||||
| Unearned revenue | |||||
| Other liabilities | |||||
| Other current liabilities | |||||
| Other long-term liabilities | |||||
| Total other liabilities | |||||
| Total adjustments | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Capital expenditures | |||||
| Investment in intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from line of credit | |||||
| Repayments of line of credit | |||||
| Proceeds from term loan and other borrowings | |||||
| Repayments of term loan and other borrowings | |||||
| Debt prepayment costs | |||||
| Fees paid for issuance of term loan | |||||
| Proceeds from issuance of common stock, net of costs | |||||
| Cash paid to satisfy tax withholding upon employee vesting | |||||
| Principal payments on capital lease obligations | |||||
| 7% Series B convertible preferred stock dividend | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from employee stock purchase | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Restricted cash (included in Other long-term assets on the Consolidated Balance Sheets) | |||||
| Total cash, beginning of period | |||||
| Total cash, end of period | |||||
| Non-Cash Investing and Financing Transactions: | |||||
| Capital lease obligations incurred | |||||
| Capital equipment purchased on credit | |||||
| Financing of intellectual property purchased, at fair value | |||||
| Issuance of warrant, at fair value | |||||
| Fair value of intellectual property purchase liability | |||||
| Supplemental Disclosures of Cash Flow Information: | |||||
| Interest paid | |||||
Loading...